The challenge of acute exacerbation of pulmonary fibrosis

Respiration

Volumn 83, Issue 1, 2012, Pages 13-16

  Antoniou, Katerina M ^a   Cottin, Vincent ^b,c  

^a UNIVERSITY OF CRETE   (Greece)

^b LOUIS PRADEL HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; DISEASE EXACERBATION; DYSPNEA; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOSPITALIZATION; HUMAN; IDIOPATHIC DISEASE; LUNG FIBROSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

ANTI-BACTERIAL AGENTS; COLLAGEN DISEASES; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; RESPIRATORY THERAPY; VASCULAR DISEASES;

EID: 84855994262     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000331458     Document Type: Review

References (29)

1. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA, Raghu G, Roman J, Ryu JH, Zisman DA, Hunninghake GW, Colby TV, Egan JJ, Hansell DM, Johkoh T, Kamin-ski N, Kim DS, Kondoh Y, Lynch DA, Muller-Quernheim J, Myers JL, Nicholson AG, Selman M, Toews GB, Wells AU, Martinez FJ: Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007; 176:636-643. (Pubitemid 47503070)
2. Huie TJ, Olson AL, Cosgrove GP, Janssen WJ, Lara AR, Lynch DA, Groshong SD, Moss M, Schwarz MI, Brown KK, Frankel SK: A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes. Respirology 2010; 15: 909-917.
3. Song JW, Hong SB, Lim CM, Koh Y, Kim DS: Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 2011; 37: 356-363.
4. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G, Brown K K: The clinica l course of patients with idio-pathic pulmonary fibrosis. Ann Intern Med 2005; 142:963-967.
5. Daniels CE, Yi ES, Ryu JH: Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J 2008; 32: 170-174.
6. Churg A, Wright JL, Tazelaar HD: Acute exacerbations of fibrotic interstitial lung disease. Histopathology 2011; 58: 525-530.
7. Park IN, Kim DS, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Jang SJ, Colby TV: Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibro-sis. Chest 2007; 132: 214-220. (Pubitemid 47068224)
8. Olson AL, Huie TJ, Groshong SD, Cosgrove GP, Janssen WJ, Schwarz MI, Brown KK, Frankel SK: Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series. Chest 2008; 134: 844-850.
9. Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, Imokawa S, Hashizume H, Naito T, Hashimoto D, Takehara Y, Inui N, Nakamura H, Colby TV, Chida K: Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 2009; 103:846-853.
10. Tachikawa R, Tomii K, Ueda H, Nagata K, Nanjo S, Sakurai, A, Otsuka K, Kaji R, Hayashi M, Katakami N, Imai Y: Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration 2012;83:20-27.
11. Simon-Blancal V, Freynet O, Nunes H, Bouvry D, Naggara N, Brillet P-Y, Denis D, Cohen Y, Vincent F, Valeyre D, Naccache J-M: Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors. Respiration 2012;83:28-35.
12. Parambil JG, Myers JL, Ryu JH: Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases. Chest 2006; 130: 553-558. (Pubitemid 44267026)
13. Tsuchiya Y, Takayanagi N, Sugiura H, Miyahara Y, Tokunaga D, Kawabata Y, Sugita Y: Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 2011; 37: 1411-1417.
14. Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, Colby TV: Prognosis of fi-brotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175: 705-711. (Pubitemid 46536486)
15. Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, Lee JS, King TE Jr, Collard HR: Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010; 35: 1322-1328.
16. Sakamoto K, Taniguchi H, Kondoh Y, Ono K, Hasegawa Y, Kitaichi M: Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease. Eur Respir Rev 2009; 18: 129-132.
17. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richel-di L, Selman M, Dudden RF, Griss BS, Protz-ko SL, Schunemann HJ: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
18. Mollica C, Paone G, Conti V, Ceccarelli D, Schmid G, Mattia P, Perrone N, Petroianni A, Sebastiani A, Cecchini L, Orsetti R, Ter-zano C: Mechanical ventilation in patients with end-stage idiopathic pulmonary fibro-sis. Respiration 2010; 79: 209-215.
19. Wuyts WA, Thomeer M, Dupont LJ, Verleden GM: An algorithm to tackle acute exacerbations in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 177:1397, author reply 1398.
20. Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, Song JW, Huh JW, Taniguchi H, Chiu C, Boushey H, Lancaster LH, Wolters PJ, De-risi J, Ganem D, Collard HR: Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 183: 169 8-1702.
21. Konishi K, Gibson KF, Lindell KO, Richards TJ, Zhang Y, Dhir R, Bisceglia M, Gilbert S, Yousem SA, Song JW, Kim DS, Kaminski N: Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 18 0: 167-175.
22. Cottin V, Le Pavec J, Prevot G, Mal H, Humbert M, Simonneau G, Cordier JF: Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105-111.
23. Antoniou KM, Hansell DM, Rubens MB, Marten K, Desai SR, Siafakas NM, Nicholson AG, du Bois RM, Wells AU: Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008; 17 7: 190-194.
24. Cottin V, Nunes H, Mouthon L, Gamondes D, Lazor R, Hachulla E, Revel D, Valeyre D, Cordier JF: Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis R heum 2011; 63: 295-304.
25. Hara S, Ishimoto H, Sakamoto N, Mukae H, Ka kugawa T, Ish i m atsu Y, Mi ne M, Kohno S: Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study. Respiration 2011; 81: 107-117.
26. Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King TE Jr, Matthay MA, Kim DS: Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010; 299:L3-L7.
27. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O'Byrne PM, Strieter RM, Kolb M: Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179: 588-594.
28. Kurosu K, Takiguchi Y, Okada O, Yumoto N, Sakao S, Tada Y, Kasahara Y, Tanabe N, Tatsumi K, Weiden M, Rom WN, Kuriyama T: Identification of annexin 1 as a novel autoan-tigen in acute exacerbation of idiopathic pulmonary f ibrosis. J Immunol 2008; 181: 756-767.
29. Egan JJ: Follow-up and nonpharmacological management of the idiopathic pulmonary fi-brosis patient. Eur Respir Rev 2011; 20:114-117.